ALK Positive Inc.
@alkpositive.bsky.social did:plc:a3h2uuwcim4i5ra3bdhd52eh
Patient-driven organization seeking a cure and working to improve patients' quality of life and life expectancy worldwide.
Sur Bluesky depuis le
- Abonnés
- 317
- Abonnements
- 350
- Posts
- 306
- Jours dans les classements
- 0
Résumé
ALK Positive Inc. (@alkpositive.bsky.social) est sur Bluesky depuis le 19 novembre 2024. Le compte a 317 abonnés, suit 350 comptes et a publié 306 posts.
Présence dans les classements
Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.
Ce compte n’est encore apparu dans aucun classement quotidien.
Posts aimés récemment
J’aime publics du réseau Bluesky.
Not all #lungcancer is the same - and neither should be our treatments. Today, we can personalize care to each person's unique biology. As Dr Lauren Byers @mdanderson.bsky.social highlights, innovation is making precision care a reality. Let’s keep pushing for more. #StoriesOfLungCancer #LCAM25
Voir le postAs Lung Cancer Awareness month comes to a close please consider buying a pair of laces & supporting much needed research into the leading cause of cancer deaths worldwide & in Australia. docs.google.com/document/d/e...
Voir le postIt’s a simple wish: to see your child grow up. But for people with ALK+ lung cancer, like Amanda, Jenna, Carla, and Hope, there are no guarantees. You can help give them more precious years with their kids by supporting research. What would you give for more time?
Voir le postSorry for both of your losses, words cannot replace what was lost😔 This troubling news came out. www.nbcnews.com/nightly-news...
Voir le post#Biomarkertesting helps people with #lungcancer get the right treatment at the right time. Yet too many still miss out. This video created w @thermofishersci.bsky.social is a great resource for anyone diagnosed. Help share to empower & inform more people👇 www.oncogeneresearch.org/biomarker-te...
Voir le post
Comptes bloqués
Sur Bluesky, les blocages sont publics.
Ce compte ne bloque personne.